Results from the first year of the pilot program show that diabetic patient testing rose by 6 percent after the first year of the ACO group. As a result, cholesterol management for diabetics increased by 8 percent.
Further, the ACO pilot showed a decrease — a 7 percent drop — in the use of imaging studies for patients with newly-diagnosed lower back pain. Decreasing the use of imaging is a target to improve quality and lower healthcare costs, according to the report.
More Articles Related to ACOs:
Report: More than 60 ACOs, Mostly Commercial, Added Since November 2011
63% of Physicians Say ACOs Will Have Negative Impact on Care
What Does it Take to Form an Oncology ACO? Q&A With Florida Blue’s Dr. Jonathan Gavras
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
